This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fournier, B. Articles by Philpott, D. J. Search for Related Content PubMed PubMed Citation Articles by Fournier, B. Articles by Philpott, D. J.

Recognition of Staphylococcus aureus by the Innate Immune System

Laboratoire des Listeria,¹ Groupe d'Immunité Innée et Signalisation, Institut Pasteur, Paris, France²

SUMMARY

INTRODUCTION

INFLAMMATORY RESPONSE TO S. AUREUS

TOLL-LIKE RECEPTOR 2

Staphylococcal Structures Recognized by TLR2

Teichoic acids. (i) Structure.

(ii) Role in the inflammatory response.

(iii) Interaction with TLR2.

Alanylation of teichoic acids. (i) Structure.

(ii) Role in the inflammatory response.

(iii) Interaction with TLR2.

Peptidoglycan. (i) Structure.

(ii) Role in the inflammatory response.

(iii) Interaction with TLR2.

Phenol-soluble modulin. (i) Structure.

(ii) Role in the inflammatory response.

(iii) Interaction with TLR2.

TLR2 Cooperation with Other Receptors

TLR1/TLR6.

CD14.

CD36.

Asialo-GM1.

Structure of TLR2

TLR2 Signaling

NOD PROTEINS

Staphylococcal Structure Recognized by Nod Proteins

Structure of Nod2

Nod Signaling

RIP2 pathway.

Interaction with the TLR pathway.

TNFR1

PEPTIDOGLYCAN RECOGNITION PROTEINS

OTHER STAPHYLOCOCCAL COMPONENTS INVOLVED IN THE INFLAMMATORY RESPONSE

Hemolysins

Formylated Peptides

Staphylococcal DNA

CONCLUDING REMARKS

ACKNOWLEDGMENTS

REFERENCES

Top Next References

INTRODUCTION

Top Previous Next References

 
Staphylococcus aureus is a major pathogen in both community-acquired and nosocomial infections. S. aureus often colonizes hosts asymptomatically and lives as a commensal of the human nose. The anterior nares are the major reservoir of S. aureus: 20% of persons are persistently colonized and 60% are intermittent carriers, whereas 20% never carry S. aureus (86). The primary site of infection is often a breach in the skin that may lead to minor skin and wound infections, but S. aureus can also infect any tissue of the body, causing life-threatening diseases such as osteomyelitis, endocarditis, pneumonia, and septicemia.

The pathogenicity of S. aureus is due to the repertoire of toxins, exoenzymes, adhesins, and immune-modulating proteins that it produces. With the exception of diseases caused by specific toxins, such as enterotoxins and exfoliative or toxic shock syndrome toxins, no single virulence factor has been shown to be sufficient to provoke a staphylococcal infection. Such infection is rather promoted by the coordinated action of various virulence factors, which are cell wall associated and secreted bacterial proteins. Indeed, both localized infections, such as soft-tissue abscesses, and life-threatening systemic diseases, such as sepsis, result from the ability of this pathogen to attach to cells or tissues; escape the host immune system, i.e., factors that decrease phagocytosis and factors that interact with antistaphylococcal antibodies; and elaborate proteases, exotoxins, and enzymes, factors that specifically cause cell and tissue damage allowing dissemination of S. aureus (154).

The expression of these virulence factor genes is controlled by several regulatory systems such as Agr, SarA, and Arl (26, 42, 129, 148). The accessory gene regulator (Agr) is one of the best-characterized global regulatory systems involved in the regulation of virulence factor genes. Indeed, Agr, which is a quorum-sensing regulatory system, regulates virulence by increasing the expression of exoprotein genes and decreasing the expression of cell wall-associated protein genes (129, 148).

Staphylococcal sepsis differs from enterobacterial sepsis in that S. aureus infection often begins from infected loci at the body surface such as skin or soft tissue infections rather than enteric or genitourinary sources (159). Furthermore, staphylococcal infection induces an influx of neutrophils. Indeed, S. aureus is a pyogenic pathogen capable of tissue invasion and evasion of phagocytosis by neutrophils. Tissue invasion and killing of phagocytes are involved in the inflammatory response that leads to septic shock (178). Even though mortality rates in systemic nosocomial infections associated with S. aureus are higher than those due to enterobacteria, they are also lower than those due to aerobic gram-negative bacilli such as Pseudomonas aeruginosa (5, 151).

S. aureus, followed by Enterococcus spp. in the United States and Streptococcus pneumoniae in Europe, is the organism most frequently isolated during invasive nosocomial infections (17, 41). The increasing frequency of gram-positive sepsis is probably due to the ability of S. aureus to colonize intravascular catheters or surgically implanted materials and to the spread of antibiotic-resistant S. aureus, such as methicillin-resistant S. aureus (143). The outer cell wall of staphylococci is composed of exposed peptidoglycan, lipoteichoic acids, and a range of other toxic secreted products, which are probably implicated in staphylococcal septic shock (178). However, no symptom of shock is observed when the serum concentration of tumor necrosis factor alpha (TNF-), one of the proinflammatory cytokines responsible for septic shock in gram-negative bacteria, is increased. This suggests that, unlike gram-negative-mediated shock, induction of TNF- is not sufficient to cause symptoms of shock in staphylococcal infection (60). Thus, the mechanisms that lead to staphylococcal septic shock are probably multifactorial (178).

Pathogens invading the host are controlled by innate and adaptive immune responses. Recognition of microorganisms is the first step of host defense. The adaptive immune system recognizes pathogens by antigen receptors that are expressed at the surface of B and T lymphocytes. These receptors are characterized by specificity and memory. However, gene rearrangement followed by T- and B-cell activation usually takes several days to be fully active and to eradicate pathogens (183). Therefore, more rapid defense mechanisms have been developed by the host through the innate immune system. This system is capable of recognizing pathogens and provides a first line of defense to the host. Indeed, the innate immune response initiates a sequence of events that results in the production and secretion of a wide range of inflammatory cytokines and chemokines, the activation of macrophages/monocytes, and the initiation of adaptive immunity. The production of proinflammatory factors is due to several cell types, including white blood cells (neutrophils and macrophages), epithelial, and endothelial cells as well as platelets. White blood cells can phagocytose, kill, and degrade the pathogen. Compounds or molecules resulting from this degradation are then presented to T cells to activate adaptive immunity (3, 169).

The role of the innate immune system is to recognize a large number of different pathogens and to discriminate them from self and also those bacteria composing the normal flora with a limited number of receptors. Furthermore, pathogens have the ability to mutate, altering phenotypic expression of virulence determinants and recognition by host receptors. Thus, the host has developed a variety of innate immune receptors that have the ability to detect different microbial motifs that are usually conserved among species (3, 77). Interestingly, the structures recognized by the innate immune system are usually essential for the invading organisms and are not present in the host cells (113).

INFLAMMATORY RESPONSE TO S. AUREUS

Top Previous Next References

 
The complex mechanisms of the host response upon invasion by pathogens include the production and release of proinflammatory and immunomodulating cytokines. Cytokines are inducible proteins that are mainly produced on stimulation of white blood cells and other cells by pathogens (197). Thus, synthesis of cytokines is necessary for the host defense against infections. Indeed, the absence of cytokines in deficient mice has been shown to be deleterious to the host (22). However, an inflammatory response with excessive production of proinflammatory cytokines induces side effects and can even lead to multiple organ dysfunction syndrome and death (22, 197).

Cells of the monocytic lineage are essential for innate immunity and also play a critical role in the pathophysiology of bacterial sepsis. Indeed, monocytes/macrophages are the main source of inflammatory cytokines responsible for septic shock (see Fig. 3). Among the different cytokines implicated in inflammation and septic shock, TNF-, interleukin-1ß (IL-1ß), and IL-6 are proinflammatory cytokines. IL-10 is an anti-inflammatory cytokine that inhibits proinflammatory cytokines such as IL-1ß, IL-6, IL-8, and TNF-. IL-8 is a strong chemoattractant for neutrophils, while MCP-1 (macrophage/monocyte chemoattractant protein-1) and MIP-1 (macrophage-inflammatory protein-1) are chemoattractive mainly for monocytes: they elicit recruitment of phagocytes to the infectious site (109) (Table 1).

View larger version (27K): [in this window] [in a new window]   FIG. 3. Action of staphylococcal components to promote immune responses from immune cells (data from reference 63). FPR, formylated peptide receptor.

As the systemic inflammatory response is involved in sepsis, it was suggested that treatment modulating or inhibiting inflammatory mediators would improve survival of patients with staphylococcal sepsis. In contrast to some animal models of gram-negative sepsis, pretreatment of animals with corticosteroids does not modify mortality when animals are challenged with S. aureus. Similar results were observed when patients with staphylococcal sepsis were treated with anti-inflammatory agents (143). Furthermore, it appears that anticytokine therapies have a detrimental effect in gram-positive sepsis (2, 143). Thus, these results suggest that gram-positive infections are more difficult to cure than those with gram-negative bacteria (178).

TOLL-LIKE RECEPTOR 2

Top Previous Next References

 
The first members of the Toll family were identified in Drosophila melanogaster. Drosophila melanogaster is very resistant to microbial infections because it can synthesize antimicrobial peptides (7). Since the production of these peptides is regulated by a Toll receptor, adult flies that are mutated in Toll are susceptible to infection by fungi and bacteria (99). Thus, Toll is an essential receptor in the innate immune recognition in Drosophila melanogaster.

By a homology search of databases, 11 homologues of Toll designated Toll-like receptors (TLRs) have been found in humans (4, 114, 224). The role of TLRs in mammals is also to participate in innate immune recognition as pattern recognition receptors that detect common bacterial motifs.

Several lines of evidence support the view that TLR2 has a broad role as a pattern recognition receptor for a variety of microbes and microbial structures. These include lipoproteins from pathogens such as mycobacteria, spirochetes, and mycoplasmas, lipoarabinomannan from mycobacteria, Trypanosoma cruzi glycosylphosphatidylinositol anchor, and zymosan from fungi (4). Furthermore, TLR2 has been reported to be involved in the recognition of staphylococcal peptidoglycan and lipoteichoic acid (LTA) (see section on staphylococcal structures recognized by TLR2) (37, 61, 101, 171, 185, 194, 195, 222).

The involvement of TLR2 has been implicated in the host response to several staphylococcal infection models. For the most part, lack of TLR2 appears to increase the susceptibility of the host to staphylococcal infections. For example, TLR2-deficient mice are highly susceptible to S. aureus when inoculated intravenously (67, 184). After subcutaneous injections, staphylococci can grow intradermally in TLR2^–/– mice, whereas they are cleared in wild-type mice (67). In addition, since nasal carriage is a major risk factor for staphylococcal infection, this parameter was investigated in TLR2-deficient mice (202). In a model of intranasal infection, TLR2-deficient mice showed 10-fold higher nasal carriage of S. aureus compared to that in wild-type mice (54). However, TLR2 deficiency has also been shown to be protective in certain infection models. One of the main components involved in the pathophysiology of sepsis is myocardial dysfunction, and it was found that in TLR2-deficient mice, the heart is protected against cardiac dysfunction caused by S. aureus. Furthermore, in this model, TNF- and IL-1ß production is significantly attenuated in TLR2-deficient mice (87). Thus, from these many investigations, it appears that TLR2 plays an important role as an innate immune receptor in the response to staphylococcal infections. However, depending on the infectious model, deficiency of TLR2 can be either protective or detrimental to the host organism.

TLR2 is expressed by different cells involved in the inflammatory response such as monocytes/macrophages, neutrophils, dendritic cells, astrocytes, and mast cells (38, 112, 164, 199). Interestingly, TLR2 and TLR6 are poorly expressed by human intestinal epithelial cells, which are broadly unresponsive to TLR2-dependent ligands such as staphylococcal phenol-soluble modulin or LTA (117).

The pathogenicity of S. aureus is postulated to depend on the expression of a wide range of cell wall-associated and secreted bacterial proteins. We will not describe in this review the role of superantigen toxins in the inflammatory response because these superantigens are encoded by accessory genetic elements not always present in the S. aureus genome. Although cell wall-associated and secreted proteins are keys for staphylococcal virulence, their role in innate immunity remains largely unknown. On the other hand, several cell wall components such as peptidoglycan and lipoteichoic acids have been well studied.

Teichoic acids. (i) Structure. Both wall teichoic acids and lipoteichoic acids are highly charged polymers. They concentrate cations at the cell wall surface and are associated with proteins to form complexes. They are involved in various biological activities: cation balance in the cell surface, cell division, and regulation of peptidoglycan autolysis (163).

S. aureus wall teichoic acid is a water-soluble polymer composed of 40 ribitol phosphate units that are substituted with D-alanine ester and N-acetylglucosaminyl residues (Fig. 1A). The chain is attached to peptidoglycan by a phosphodiester bond through a linkage unit that is composed of three glycerophosphate residues linked to two amino sugars (Fig. 1A).

View larger version (22K): [in this window] [in a new window]   FIG. 1. Structures of teichoic acid (A) and lipoteichoic acid (B) of S. aureus (data from references 39 and 163). NAG, N-acetylglucosamine.

(ii) Role in the inflammatory response. Although crucial for bacterial life, purified wall teichoic acids of S. aureus are not very inflammatory (108). However, a number of studies suggest that the bacterial LTA of S. aureus may contribute to sepsis (83). LTA from S. aureus has been shown to provoke secretion of cytokines and chemoattractants (TNF-, IL-1ß, IL-10, IL-12, IL-8, leukotriene B4, complement factor 5a, MCP-1, MIP-1 and granulocyte colony-stimulating factor) from monocytes or macrophages (14, 27, 30, 81, 179, 200). Complement factor 5a and leukotriene B4 are chemoattractants active on polymorphonuclear cells (PMNs) and monocytes. Thus, LTA induces an inflammatory response. However, very large amounts of LTA are necessary to induce responses of cells in vitro. Indeed, LTA, in the 1 to 10 µg/ml range is required to trigger cellular responses while LPS in the ng/ml range is sufficient to elicit responses (94). It must be taken into consideration that the active concentrations of LTA (1 µg or 10⁵ to 10⁷ CFU) as well as of LPS (20 ng or 10⁷ CFU) are comparable when they are transposed to bacterial cell equivalents (170, 200), suggesting that LTA and LPS preparations may have similar potency.

Comparison of the activity of LPS versus LTA showed that staphylococcal LTA is able to promote the same strong induction of chemoattractants (IL-8, MIP-1, MCP-1, complement factor 5a, and leukotriene B4), granulocyte colony-stimulating factor, and anti-inflammatory cytokines (IL-10) as LPS, whereas it is a weaker inducer of TNF-, IL-1ß, and IL-6 (200, 201). LTA also induces less IL-12 than LPS and subsequently IFN- (64, 91). The cytokine pattern produced by LTA is similar to that induced by the whole bacterium (200, 210). Furthermore, when LTA is inoculated intranasally in mice, a strong neutrophil and macrophage infiltration is observed in the lung, suggesting that LTA elicits granulocyte recruitment by producing chemoattractants (200). It is likely, then, that staphylococcal LTA participates in the formation of pus by recruiting neutrophils (200). Thus, staphylococcal LTA is a strong inducer of chemoattractant and granulocyte colony-stimulating factor release, suggesting that it is not just a weak LPS-like molecule but indeed displays activities distinct from LPS.

(iii) Interaction with TLR2. LTA causes cytokine induction in mononuclear phagocytes. It was thus tempting to imagine that TLRs transduce the signal necessary for activation of immune cells by LTA. However, the role of TLRs in LTA-induced cell stimulation as well as the stimulation of cytokine production obtained in different cell systems has been controversial (14, 81, 94, 132, 171, 185). In most of these studies, commercial staphylococcal LTA preparations were used. It has been demonstrated that these preparations have a high degree of compositional heterogeneity and also contain significant amounts of endotoxin (the origin of this endotoxin is unknown) (45, 126). Furthermore, purification of LTA from S. aureus by standard methods using phenol extraction results in hydrolysis of D-alanine substituents. These substituents have been shown to be crucial for biological activity of LTA (125) (see section on alanylation of teichoic acids). Thus, taken together, the heterogeneity of the preparations, contamination by endotoxin, and inappropriate methods of purification that result in partial degradation of LTA might explain contradictory results in the literature concerning the role of TLR in the transduction of the signal and the production of cytokines after staphylococcal LTA stimulation (126).

A novel purification method using butanol extraction produces staphylococcal LTA without LPS contamination. This LTA exhibits the same efficiency, pattern of cytokine induction (TNF-, IL-1ß, IL-6, and IL-10), and recognition by TLR as a chemically synthesized LTA (45, 98, 125, 127). By using TLR2-deficient mice or monoclonal antibodies to TLR2, production of cytokines, e.g., IL-6 and TNF-, in response to LTA stimulation requires TLR2 (38, 59, 121, 185), suggesting that TLR2 is a key receptor in response to LTA of S. aureus.

Although LTA exists as a heterogeneous family of related molecules, it appears that no relationship between LTA structure and efficiency is observed. However, several LTA compounds, such as D-Ala constituents, the glycosyl substituents, and the lipid anchor, modify LTA activity (64, 127, 128). Furthermore, LTAs from S. aureus and Bacillus subtilis exhibited similar TLR2 induction (144), whereas pneumococcal LTA is less active than staphylococcal LTA in stimulating TLR2 (59, 192). Taken together, LTA appears to constitute a broad immunostimulatory factor of gram-positive bacteria with possibly differing potencies depending on the constituents of the molecule (47, 64).

Alanylation of teichoic acids. (i) Structure. The D-alanyl ester of teichoic acids results from a D-alanine substitution on the sugar (Fig. 1). The products of an operon of the S. aureus chromosome, dltABCD (for D-alanyl-LTA), catalyze the introduction of D-Ala into both wall teichoic acids and LTA. D-Alanylation of teichoic acids modulates the properties of the envelope. Indeed, D-alanine-esterified teichoic acids protect S. aureus against cationic antimicrobial peptides produced by host (150). Furthermore, the degree of D-alanylation is affected by growth environment (90, 135). In a culture at low salt concentrations, the degree of alanylation is 60% for wall teichoic acids and 80% for staphylococcal LTA (39).

(ii) Role in the inflammatory response. Alanylation of teichoic acids increases the release of TNF- and MIP-2 (93): in mice, MIP-2 and keratinocyte chemoattractant may serve as a neutrophil chemotactic factors in the recruitment of PMNs to sites of infection and inflammation because IL-8 is not present in mice (97). D-Alanine has been shown to be an important substituent for LTA activity since hydrolysis of alanine substituents of active LTA dramatically decreases cytokine induction (125). Furthermore, alanylation of teichoic acids increases the virulence of S. aureus in mice (28). The inflammatory response due to D-alanylation is correlated with the number and survival of bacteria (93). Indeed, dlt-deficient S. aureus are cleared more rapidly than the wild-type strain after administration of a similar inoculum. The lack of alanylation has three considerable consequences: increased susceptibility to defensin-like antimicrobial peptides (150), reduced adherence to host cells (1), and reduced inflammatory activity of LTA. Thus, alanylation induces multiple changes affecting the outcome of in vivo experiments.

(iii) Interaction with TLR2. The minimum infective doses for wild-type S. aureus and dlt-deficient bacteria in TLR2^–/– mice are 10-fold and 500-fold lower, respectively, than those observed in wild-type mice (93), suggesting that TLR2 is involved in murine host defense against alanylated staphylococcal teichoic acids. Since both wall teichoic acids and LTA are D-alanylated, this result confirms that TLR2 stimulates cytokine production in response to alanylated LTA (185, 201). However, the role of alanylated wall teichoic acids in TLR2 stimulation remains unknown.

Even in TLR2^–/– mice, dlt-deficient bacteria have a higher minimum infective dose than the wild-type strain (93). Furthermore, release of MIP-2 and TNF- occurs in TLR2-deficient mice. These results suggest that additional host defense mechanisms not related to TLR2 are involved. Thus, a receptor distinct from TLR2 or another mechanism also seems to be involved in the inflammatory response of mice to S. aureus alanylated teichoic acids (93).

Peptidoglycan. (i) Structure. Peptidoglycan is a large polymer and the most conserved component of the gram-positive envelope. It provides shape-determining properties for bacteria. This polymer is constituted of glycan strands of two alternating sugar derivatives, N-acetylglucosamine and N-acetylmuramic acid, which form a dissacharide subunit. The carboxyl group of N-acetylmuramic acid is linked to a peptide subunit (or stem peptide) consisting of four or five alternating L- and D-amino acids (Fig. 2). This structure is highly cross-linked by peptide bridges (95). Whereas the structure of the glycan chains is highly conserved, the composition of the stem peptide varies among bacterial species. Indeed, most gram-negative bacteria and gram-positive bacilli possess m-diaminopimelic acid in position 3 of the stem peptide, which is usually directly cross-linked. In contrast, gram-positive cocci such as S. aureus have L-lysine in position 3 of the stem peptide that is cross-linked via an "interpeptide bridge," the composition of which is different among bacteria (34, 167) (Fig. 2). Staphylococcal peptidoglycan belongs to this second type and has a pentaglycine interpeptide bridge (Fig. 2).

View larger version (27K): [in this window] [in a new window]   FIG. 2. Structure of peptidoglycan of S. aureus and several other bacteria. The peptidoglycan of gram-negative bacteria and gram-positive bacilli is indicated on the right. Digestion by different enzymes (glucosaminidase, muramidase, amidase, and endopeptidase) is shown by dotted arrows. MDP structure is indicated in the dotted square. NAG, N-acetylglucosamine; NAM, N-acetylmuramic acid; m-DAP, m-diaminopimelic acid.

Peptidoglycan hydrolases are present in all bacteria, and some of them, called autolysins, digest their own protective cell wall peptidoglycan. Since peptidoglycan is essential for cellular integrity, the action of autolysins usually results in bacterial autolysis. Lysostaphin, which is an endopeptidase produced by Staphylococcus simulans biovar staphylolyticus, cleaves staphylococcal peptidoglycans in general (189) (Fig. 2). When lysing staphylococci, the enzymatic reaction of lysostaphin is the specific hydrolysis of the Gly-Gly bond in the pentaglycine bridge of the staphylococcal peptidoglycan.

Host enzymes are also implicated in peptidoglycan cleavage. Lysozyme is a muramidase present in various tissues (mucous membranes, respiratory and intestinal tracts) and fluids (serum, saliva, and tears). It is important for host defense because it can kill bacteria. Interestingly, S. aureus is resistant to lysozyme because N-acetylmuramic acid of staphylococcal peptidoglycan is O-acetylated at position C6-OH (Fig. 2) by an O-acetyltansferase that is an integral membrane protein (13). The resistance of S. aureus to lysozyme may contribute to its ability to colonize the skin and mucosal tissues such as the anterior nares. Peptidoglycan recognition protein L (PGRP-L), also known as serum amidase, displays an N-acetylmuramoyl-L-alanine amidase activity towards peptidoglycan. PGRP-L is thought to function as a peptidoglycan-scavenging molecule that likely reduces peptidoglycan-induced inflammation (209) (see section on PGRPs below).

(ii) Role in the inflammatory response. Staphylococcal peptidoglycan has been shown to stimulate the production of proinflammatory cytokines and chemokines (TNF-, IL-1ß, IL-6, and IL-8) in monocytes and macrophages (66, 110, 190, 205). It has also been observed that primary astrocytes produce numerous cytokines such as IL-1ß, TNF-, MIP-1ß, and MCP-1 in response to staphylococcal peptidoglycan (38) (Fig. 3).

Larger amounts of peptidoglycan, in the 10 to 100 µg/ml range, are necessary to stimulate cellular responses compared to LPS, which induces responses in the ng/ml range (94). Since 1 x 10⁶ to 6 x 10⁶ CFU correspond to 1 µg of staphylococcal peptidoglycan (192), whereas 10⁷ CFU correspond to 20 ng of LPS, this suggests that whole peptidoglycan is about 100-fold less active than LPS. Studies of S. aureus cell walls indicate that only part of peptidoglycan is active. Indeed, insoluble and soluble peptidoglycan chains of high molecular weight are not very inflammatory. Hydrolyzing these chains to sugar and peptide monomers completely abolishes inflammation. In staphylococcal peptidoglycan, three cross-linked stem peptides appear to be the minimal structural constraint to be inflammatory (128). Furthermore, treatment of S. aureus by lysostaphin, which cleaves the pentaglycine bridge, moderately attenuates release of cytokines, whereas digestion with cellosyl, a muramidase hydrolyzing glycosidic bonds, nearly abrogates the induction of cytokine (131, 223). This suggests that the glycan strand is crucial for cytokine production, whereas stem peptide structure does not seem to be critical for the inflammatory activities of peptidoglycan.

Although peptidoglycan by itself promotes a weak induction of cytokines, it shows synergistic effects with LTA or LPS (221). Indeed, intravenous administration of staphylococcal peptidoglycan or LTA alone cannot cause shock, whereas coadministration of peptidoglycan with LTA in rats induces the production of TNF- and IFN- in a synergistic way and provokes septic shock and multiple organ failure (31, 83, 188). Furthermore, although intranasally inoculated LTA does not synergize with peptidoglycan to induce the production of TNF- and the chemoattractants MIP-2 and keratinocyte chemoattractant, these staphylococcal components act in synergy to elicit recruitment of PMNs into mouse lung (97).

Peptidoglycan of S. aureus also synergizes with low doses of LPS to cause multiple organ failure (188). Furthermore, coinjection of peptidoglycan with LPS induces synergistic production of TNF- and IL-6 in the blood. Surprisingly, the release of IL-10 was not modified by the coadministration of peptidoglycan with LPS (188, 207). Thus, peptidoglycan seems to synergize with LPS to induce the release of proinflammatory cytokines but not the anti-inflammatory cytokines.

(iii) Interaction with TLR2. The role of TLR2 as a peptidoglycan receptor has been investigated extensively, and until recently, it was broadly accepted that TLR2 is a receptor for staphylococcal peptidoglycan (76, 164, 171, 185). Indeed, staphylococcal peptidoglycan binds strongly to a soluble form of recombinant TLR2 composed of its putative extracellular domain, suggesting that the extracellular TLR2 domain directly interacts with peptidoglycan (76).

However, there are now contradictory results about the role of TLRs in peptidoglycan-induced cell stimulation and cytokine production. Most studies have been mainly carried out with commercial S. aureus peptidoglycan preparations, and a recent publication showed that highly purified peptidoglycan did not elicit TLR2-dependent activation and IL-6 and TNF- production from mouse peritoneal macrophages, whereas lipoproteins and LTA did. It was hypothesized that the stimulation of TLR2 by peptidoglycan could be attributed to other inflammatory cell wall components contaminating the commercial peptidoglycan preparations (192). Indeed, treatment of peptidoglycan with hydrofluoric acid abolished TLR2 stimulation by gram-positive cell walls. As hydrofluoric acid hydrolyzes LTA, it was suggested that the peptidoglycan contaminant could be LTA (192). Thus, it seems that staphylococcal peptidoglycan is probably not recognized by TLR2 but rather by Nod2, another innate immune receptor (see section on Nod proteins).

Phenol-soluble modulin. (i) Structure. Although infections with Staphylococcus epidermidis are less severe than those with S. aureus, S. epidermidis can cause infections ranging from localized infections to sepsis. This bacterium releases phenol-soluble modulin (PSM) in the extracellular fluid (115). PSM is composed of at least three components, PSM, PSMß, and PSM, which are very small proteins of 22 to 25 amino acids. PSM is identical to S. epidermidis -hemolysin, which is also present in S. aureus. -Hemolysin can be formylated (see section on formylated peptides). PSM is released into the culture medium during overnight culture and is also detected in the supernatant fluid after vigorous vortexing of washed bacteria, suggesting that PSM is also partially bound to the cell surface (85).

(ii) Role in the inflammatory response. The -hemolysin of S. aureus may be involved in staphylococcal virulence. Indeed, it has been shown to lyse erythrocytes, probably by crossing the lipid membrane and inducing the release of their contents (152). It also binds to neutrophils and monocytes, inducing the production of TNF- (168). S. epidermidis PSM also induces cytokine production (TNF-, IL-1ß, and IL-6) and activates NF-B in macrophages. Furthermore, PSM is a chemotactic agent for both neutrophils and monocytes (102).

(iii) Interaction with TLR2. PSM has been shown to use TLR2 to modulate the immune response (58). Indeed, human dermal endothelial cells express only very little TLR2 and do not respond to several TLR2 ligands such as PSM. On the other hand, endothelial cells that are transfected with TLR2 are capable of responding to TLR2 ligands, including PSM (19). Although further studies are required to demonstrate conclusively the role of TLR2 in PSM recognition, it appears that this staphylococcal virulence factor is involved in the inflammatory response through its activation of TLR2.

TLR1/TLR6. Ligand recognition is more complicated with TLR2 because it has been shown to cooperate with TLR1 and/or TLR6 to increase its range of pathogen-associated molecular patterns. Ozinski et al. (145) first suggested that TLR2 mainly recognizes its ligands by forming functional heterodimers with either TLR1 or TLR6 (84, 214). TLR2 appears to require a partner to stimulate cytokine production. Indeed, dimerization of the cytoplasmic domain of TLR2 does not elicit TNF- induction (145). TLR1 and TLR6 have been shown to mediate the discriminatory recognition of triacyl and diacyl lipopeptides by TLR2. TLR6 is necessary for TLR2 to detect MALP2 (macrophage-activating lipopeptide 2 from Mycoplasma pneumoniae), which is only diacylated (186). In contrast, TLR1 is necessary for the response to triacyl lipopeptides and mycobacterial lipoproteins (165, 187). Since staphylococci also produce a set of lipoproteins, such as the ABC transporters, it will be interesting to examine the possibility that these lipoproteins are indeed detected by TLR2 and whether their form, either diacylated or triacylated, dictates the contribution of either TLR1 or TLR6 to their recognition.

TLR6 has been shown to cooperate with TLR2 in the recognition of S. aureus (137, 145). Indeed, in the presence of a dominant negative form of TLR6, cytokine production induced by S. aureus is abolished (145). However, macrophages from TLR6-deficient mice stimulated by staphylococcal peptidoglycan still produce TNF-, suggesting that TLR6 is not absolutely necessary for peptidoglycan recognition (4, 186). In TLR6^–/– fibroblasts, the staphylococcal LTA response is significantly attenuated compared to wild-type cells, suggesting that TLR6 is required for LTA recognition by TLR2 (130). However, it has also been shown that TLR2 synergizes with TLR1 to sense LTA, consistent with the fact that this product is diacylated (192). The TLR2-mediated activation of NF-B by PSM is increased by TLR6 but attenuated by TLR1 (58). Although definitive experiments in TLR1-deficient mice are still lacking, these results confirm a functional interaction between these receptors and interaction of staphylococcal components.

CD14. CD14 is a member of the family of glycosylphosphatidylinositol-anchored membrane proteins lacking an intracellular signaling domain. CD14 is a key coreceptor expressed on the surface of macrophages and PMNs and is necessary for the full induction of an inflammatory response by LPS-stimulated TLR4 (217). Several studies have demonstrated that different components of S. aureus such as peptidoglycan and LTA also interact with the CD14 molecule (27, 36, 56, 59, 78, 94, 155, 170, 171, 212). Thus, it has been suggested that CD14 is a functional receptor for staphylococcal peptidoglycan and LTA. However, as it has recently been shown that LTA contamination could be involved in the inflammatory activity due to commercial preparations of peptidoglycan (192), the question is whether or not it is indeed peptidoglycan that binds to CD14.

An anti-CD14 antibody that abolishes cytokine release induced by LTA does not reduce the cytokine production caused by LPS, whereas two other antibodies have similar inhibitory effects. This suggests that the CD14 sites that recognize LTA and LPS are distinct with perhaps an overlap (56, 64). Furthermore, cytokine induction by LTA is inhibited by soluble CD14, suggesting that LTA trigger monocyte activation via CD14 (64). In addition, expression of CD14 in fibroblasts synergistically increases NF-B activation mediated by TLR2 in response to S. aureus (222). However, the same mortality and symptoms of shock are observed in both wild-type and CD14-deficient mice challenged with various doses of S. aureus. This result suggests that CD14 does not have a significant role in septic shock caused by S. aureus (60). Thus, other CD14-independent mechanisms might be involved in TLR2 activation (60, 195).

CD36. CD36, a single polypeptide membrane glycoprotein, is a member of a family of scavenger receptors. Recently, it has been shown that CD36-mutant mice are hypersusceptible in two models of staphylococcal infections (cutaneous and systemic) (67). Furthermore, cytokine production is abolished in CD36-deficient macrophages after stimulation by LTA and the R-enantiomer of MALP2 but is normal when stimulated by other TLR2 ligands such as S-MALP2, triacylated lipopeptide, and zymosan (67). As both LTA and MALP2 are diacylated, this suggests that CD36 is involved in the recognition of diacylglycerides. Interestingly, in TLR2-deficient cells, expression of CD36 or TLR6 alone does not induce NF-B activation by LTA, suggesting that these receptors need a partner to transduce the LTA signal to cellular responses. Indeed, coexpression of either CD36 or TLR6 with TLR2 significantly increases the TLR2 response to LTA. When TLR2, TLR6, and CD36 are expressed together, the highest NF-B activation is observed. Thus, it seems that CD36 may play a role analogous to that of CD14 by concentrating the diacylglyceride signal for transduction through TLR2 (67).

Asialo-GM1. S. aureus is known to cause pulmonary infections. Once staphylococci are in the lung, they multiply and sometimes invade the epithelium of the bronchioli. The production and release of cytokines and chemokines, including IL-8, due to the presence of S. aureus elicit infiltration of PMNs and macrophages, leading to tissue damage and subsequent pneumonia (138).

In airway epithelium, asialylated glycolipids such as asialo-GM1 (asialoganglioside gangliotetraosylceramide) (153) are present on the epithelial surface and can act as receptors. Indeed, S. aureus binds to the GalNacß1-4Gal moiety exposed at the cell surface and initiates IL-8 production through NF-B activation (158). A recent study found small amounts of TLR2 on the apical surfaces of airway epithelial cells. After stimulation with S. aureus, TLR2 and asialo-GM1 are mobilized into lipid raft structures on the surface of the epithelial cells. The lipid raft microdomains are necessary for IL-8 production (176). Thus, asialo-GM1, similar perhaps to CD36, serves as a coreceptor that amplifies the signaling function of TLR2 (176).

Interestingly, the S. aureus strain lacking Agr, a staphylococcal virulence regulator (see the Introduction), shows attenuated IL-8 production through asialo-GM1, suggesting that the staphylococcal ligand recognized by asialo-GM1 is probably a surface molecule regulated by Agr such as these adhesins that interact with extracellular matrices (158).

View larger version (14K): [in this window] [in a new window]   FIG. 4. Domain structure of TLR2 (A) and Nod2 (B). Numbers correspond to amino acid residues. A. TLR2 structure (data from references 44 and 118). ECD, extracellular domain; TMD, transmembrane domain; ICD, intracellular domain; TIR, Toll/IL-1 receptor domain. The regions homologous to LRRs are indicated by square boxes, and LRR-like motifs are indicated by boxes with an asterisk. B. Nod2 structure (data from reference 141). CARD, caspase-activating and recruitment domain; NBS, nucleotide binding site and LRR domain.

The cytoplasmic portion of Toll-like receptors shows a high similarity to that of the IL-1 receptor family and is now called the Toll/IL-1 receptor (TIR) domain (182). Upon extracellular stimulation, the TIR domain associates with an adaptor protein, which actuates a succession of signaling proteins, and this cascade of activation mediates signal transduction. Several polymorphisms located in the TIR domain of TLR2 have been detected. The presence of the Arg677Trp or Arg753Gln mutation in the TIR domain reduces NF-B activation and cytokine production in response to TLR2 ligands (16, 105, 201). Furthermore, the ArG753Gln polymorphism has been shown to be present in 2 out of 91 septic patients, and these patients developed staphylococcal infections (105). However, a study of 420 patients exhibiting severe S. aureus infection showed that the Arg753Gln polymorphism in the TIR domain of the TLR2 gene is not associated with susceptibility to severe disease caused by S. aureus (124). These contradictory results might be explained by a previous observation indicating that the presence of only one wild-type allele of TLR2 is sufficient in vitro to induce normal cytokine production in response to staphylococcal LTA (124, 201).

View larger version (34K): [in this window] [in a new window]   FIG. 5. Different signaling pathways of TLR2, Nod, and TNFR1 in response to ligand, resulting in activation of NF-B, the nuclear transcriptional factor responsible for regulation of the immune response genes (data from references 3, 113, and 194). RIP1, receptor-interacting protein 1; FADD, Fas-associated death domain protein; TRAF2, TNF receptor-associated factor 2; PI3K, phosphatidylinositol 3-kinase composed of two subunits (p85 and p110).

Indeed, TLR2 represents a more simplified signaling pathway mediated mainly by the adaptors MyD88 (myeloid differentiation protein) and TIRAP/Mal (TIR-associated proteins, also termed MAL for MyD88-associated ligand), which regulate the NF-B pathway and an additional adaptor, Tollip (Toll-interacting protein), which appears to play a regulatory role in the pathway. From these adaptors, a cascade of events involving different mediators such as IRAK (IL-1R-associated kinase), TRAF6 (TNF receptor-associated factor 6), TAK1 (Transforming growth factor-activated kinase), and IKKs leads to the activation of NF-B (Fig. 5) (208). Since there are many excellent recent reviews describing the activation of the NF-B pathway, the following will focus on a description of the upstream events involving the specific adaptors of the TLR2 pathways (Fig. 5).

MyD88 also possesses a C-terminal TIR domain that interacts with the TIR domain of the TLR receptor (Fig. 5). Activation of a TLR by the ligand promotes its dimerization and the TIR domains of TLR and MyD88 bind. MyD88-deficient mice are more susceptible to systemic S. aureus infection than wild-type mice (184). Furthermore, cytokine production is attenuated in MyD88-deficient macrophages after S. aureus stimulation (183, 184). In contrast to systemic and in vitro infection, however, MyD88-deficient mice intranasally inoculated with S. aureus do not show an increase susceptibility to pulmonary infections and cytokine production as well as the neutrophil recruitment is not impaired, suggesting that lung tissues do not need MyD88 to respond to staphylococcal infections (173). Thus, the importance of MyD88 in the TLR2 signaling pathway appears to be tissue specific. This suggests that the pulmonary innate immune response to S. aureus implicates TLR2 signaling pathways distinct from MyD88 or recognition of staphylococcal ligands by a receptor independent of TLR2 (173).

TIRAP/Mal, similar to MyD88, contains a C-terminal TIR domain that directly interacts with the TIR domain of TLR2 (183). Indeed, cells from TIRAP/Mal knockout mice are unresponsive to TLR2 ligands. TIRAP/Mal, therefore, seems to be essential for signaling pathways activated by TLR2 (69, 141, 219).

An additional adaptor molecule, Tollip, has also been proposed to interact with TIR domains. Tollip was first identified as a molecule that associates with the cytoplasmic domain of IL-1R (20) and was shown to bind directly with TLR2 (225). In contrast to the other adaptor molecules, Tollip appears to suppress the TLR2 signaling pathway. Indeed, cells that overexpress Tollip cannot induce NF-B activation in response to TLR2 ligands (20). Tollip associates and interferes with IRAK, one of the key molecules involved in the TLR2 signaling pathway (Fig. 5) (20, 225).

In addition to the MyD88-Tollip-TIRAP/Mal pathway of NF-B activation, it has been observed that activation of Rac1, which belongs to the Rho family of GTPases, is also implicated in the signaling pathway of TLR2 (Fig. 5). Indeed, stimulation by S. aureus leads to association of Rac1 with the TLR2 cytosolic domain and the activation of the phosphatidylinositol 3-kinase pathway. This event induces the activation of protein kinases such as Akt (serine/threonine kinase) mediating NF-B transactivation (Fig. 5) (8).

NOD PROTEINS

Top Previous Next References

 
As stated above, TLR2 is an essential receptor for the recognition of staphylococcal components. However, it is interesting that astrocytes or macrophages from TLR2-deficient mice stimulated by S. aureus still produce proinflammatory mediators (38, 100, 184), suggesting that alternative receptors are also implicated in S. aureus recognition. The TLRs are involved in recognition of pathogens in the extracellular compartment, whereas the NBS-LRR (for nucleotide-binding site and leucine-rich repeat) family of proteins is involved in intracellular sensing of microorganisms and their products (9, 23). In this family, nucleotide-binding oligomerization domain proteins Nod1 and Nod2 play a role in the innate immune response by regulating the cytokine induction initiated by bacterial ligands through pathways that are possibly independent of TLR signaling.

The 302insC frameshift mutation in the nod2 gene is associated with the inflammatory bowel disease Crohn's disease (71, 139). This disease is associated with a severe inflammatory reaction at the level of the intestinal mucosa. Contrary to the expected gain-of-function mutation that would be consistent with the auto-inflammatory nature of this disease, the frameshift mutation in Nod2 results in a loss of bacterial sensing and decreased activation of inflammatory pathways (49, 75, 139). Much research is now focused on trying to find the mechanisms of Nod2 function that reconcile the apparently paradoxical role of this pattern recognition receptor in the pathogenesis of disease as reviewed by Kelsall (82).

Although much work is still required to fully understand Nod2 function in mediating disease, two recent papers have attempted to shed light on this issue (89, 107). One study used Nod2-deficient mice that have a "knock-in" of a mutation in Nod2 corresponding to the human Nod2 frameshift mutation associated with Crohn's disease (107). Surprisingly, these mice have high background inflammatory signaling and amplified responses to muramyl dipeptide (MDP), the specific ligand of Nod2 (see section on staphylococcal structure recognized by Nod proteins). Although these observations fit very well conceptually with the phenotype of Crohn's disease, i.e., increased levels of inflammation, they are diametrically opposed to findings in Crohn's disease patients. Cells from patients with the Nod2 frameshift mutation have normal basal levels of inflammatory signaling and are refractory to MDP stimulation (75). Thus, any firm conclusions regarding this study await confirmatory findings.

The other recent paper on mechanisms of Nod2 function demonstrated that Nod2-deficient mice have lower expression of alpha-defensins, or cryptins, at the level of the intestinal mucosa, and consequently, these mice have an increased susceptibility to oral infection with Listeria monocytogenes, a gram-positive pathogen of humans that crosses the intestinal barrier to enter the host (89). Alpha-defensins are a class of antimicrobial peptides secreted by specialized cells of the intestinal epithelium called Paneth cells. Decreased expression of alpha-defensins has also been observed in Crohn's disease patients (211). Accordingly, Nod2 mutations may render the intestinal mucosa more accessible to bacterial translocation with a resulting overamplified inflammatory response in the afflicted patient.

Since Nod1 and Nod2 are cytoplasmic proteins, the question has been raised whether or not bacteria such as S. aureus could be sensed by this class of pattern recognition receptors. Indeed, highly purified peptidoglycan does not induce cytokine production in epithelial cells expressing Nod2, suggesting that peptidoglycan must penetrate the cells to stimulate Nod proteins (57, 192). Although classically thought of as an extracellular bacterium, several observations indicate that S. aureus may also be an intracellular pathogen. S. aureus has been shown to be internalized by different mammalian cells (pulmonary epithelial cells, enterocytes, fibroblasts, endothelial cells, osteoblasts, and neutrophils) (6, 10, 11, 18, 55, 65, 70, 79, 119) in a manner dependent on the expression of the virulence regulators Agr and SarA (213). Intracellular staphylococci are sometimes present within vacuoles, but the majority appear to be free and replicating within the cytoplasm, having escaped from the endosome (70, 119). Agr is necessary for endosomal escape, probably by regulating the expression of membrane-active toxins (156, 172). Interestingly, neutrophils of patients with Crohn's disease show increased intracellular survival of S. aureus (29, 216). Thus, it is imaginable that peptidoglycan fragments from cytoplasm-dwelling bacteria could be available for recognition by Nod2 and initiate Nod-dependent cellular responses.

For the most part, however, S. aureus is classically considered an extracellular pathogen because it is found within the extracellular space during the course of a bacterial infection. Once within the host, the action of host and/or bacterial enzymes somewhat modifies the structure and composition of peptidoglycan and thereby can participate in Nod-dependent detection. On the host side, lytic enzymes such as lysozyme and amidases are known to degrade peptidoglycan polymers. The peptidoglycan of S. aureus, however, is resistant to lysozyme, and amidase digestion liberates fragments that are not detected by Nod2 (51). On the bacterial side, autolysins may contribute to staphylococcal lysis. Thus, MDP that is released when bacteria lyse can then be internalized into phagocytic cells and activate Nod2. Indeed, it has been shown that MDP is also able to be taken up by peptide transporters such as human PepT1 (196). It is also possible that phagocytic cells contain intracellular hydrolases capable of digesting bacterial peptidoglycan from phagocytosed bacteria and then releasing muropeptides active towards Nod2 into the cytosol.

Although the findings discussed here suggest that Nod2 should be capable of detecting S. aureus, it is not yet clear how this intracellular pattern recognition receptor contributes to innate immunity following infection by this organism. Studies of S. aureus infection of Nod2-deficient mice have yet to be described.

Interaction with the TLR pathway. Another pathway involved in Nod signaling has recently been described. TAK1 is required for Nod2-induced NF-B activation. Indeed, activation of NF-B by Nod2 is inhibited by a dominant negative form of TAK1 (25). Furthermore, the Nod2 LRR domain appears to interact directly with TAK1 and to inhibit TAK1-induced NF-B activation. The wild-type LRR of Nod2 is more efficient to suppress TAK1-induced NF-B activation than the LRR with a 302insC mutation (Fig. 5) (25). For the moment, however, the role of TAK1 in Nod2 sensing of bacterial ligands has not been confirmed in in vivo studies.

Interestingly, RIP2-deficient cells show reduced cytokine production when TLR2 is stimulated by its ligand, suggesting that RIP2 is necessary for optimal signaling through TLR2 (Fig. 5) (88). Taken together, these results suggest that the Nod2 and TLR2 pathways may interact with each other and explain one aspect of Nod-TLR cross talk.

TNFR1

Top Previous Next References

 
TNF- receptor 1 (TNFR1) is a receptor for TNF- that is widely expressed on the airway epithelium. An exciting recent study showed that protein A interacts directly with TNFR1. Protein A, which is a major surface protein of S. aureus strains, is covalently anchored to the peptidoglycan and belongs to the cell wall-associated virulence factors of S. aureus. Purified protein A elicits release of IL-1ß, IL-4, IL-6, IL-8, and IFN- and weak release of TNF- from monocytes and fibroblasts (149, 193). This virulence factor has also been shown to contribute to staphylococcal sepsis. Indeed, intravenous administration of protein A-deficient S. aureus to mice causes lower mortality than the wild-type strain (146).

It has been shown that TNFR1 recognizes S. aureus and its cell wall-associated protein A. Indeed, protein A binds to TNFR1 and reproduces the effects of TNF-, the ligand of TNFR1. Activation of the TNFR1 pathway by protein A induces mobilization and shedding of TNFR1 into the extracellular compartment. It also induces IL-8 production and PMN recruitment through NF-B activation (Fig. 5) (53). In the presence of a dominant-negative form of TLR2 and TLR4, protein A still induces NF-B activation in airway epithelial cells, suggesting that TLR2 or TLR4 agonists do not contaminate protein A preparations (53). Challenge of TNFR1-deficient mice resulted in reduced pneumonia and mortality in a mouse pneumonia model of infection with wild-type S. aureus. Similarly, the absence of staphylococcal protein A also reduces pneumonia and mortality in the same model with wild-type mice (53). Moreover, protein A expression is induced in S. aureus isolated from patients with pulmonary infections (52). Thus, these results suggest that protein A may be involved in the pathophysiology of pneumonia caused by S. aureus by activating TNFR1 and inducing a strong inflammatory response characteristic of PMN infiltration that is deleterious to the host. Although molecular studies on the interaction of protein A with TNFR1 are still lacking, this study opens up the possibility of novel therapeutic strategies against staphylococcal disease.

PEPTIDOGLYCAN RECOGNITION PROTEINS

Top Previous Next References

 
Peptidoglycan is an obvious target of the innate immune system since it is a structural cell wall molecule that is conserved among bacterial species and is not found in the host. Furthermore, it is essential for the survival of bacteria such as S. aureus (34).

Peptidoglycan recognition proteins (PGRPs) were isolated first in Drosophila melanogaster because they are able to interact with peptidoglycan with high affinity and are implicated in resistance to gram-positive bacteria (120). The family of peptidoglycan recognition proteins is conserved from insects to mammals. Peptidoglycan is detected in different compartments depending on the type of the mammalian PGRPs, which can be membrane bound, stored in vesicles, or secreted into the extracellular space. Four PGRPs are present in humans, PGRP-S, PGRP-L, PGRP-I, and PGRPIß, each containing at least three conserved peptidoglycan-binding domains (34, 50, 104).

PGRP-S, the best-studied mammalian PGRP, is found in the neutrophil tertiary granules, attenuates the growth of gram-positive bacteria, and induces their intracellular killing (35, 103). PGRP-S-deficient mice that are intraperitoneally inoculated are more susceptible to infections with nonpathogen gram-positive bacteria such as B. subtilis, but they show no enhanced susceptibility to virulent gram-positive bacteria such as S. aureus (35). Thus, PGRP-S is probably another antibacterial protein present in PMNs that contributes to innate immune activity against low-virulence gram-positive bacteria. Surprisingly, however, it does not seem to act on S. aureus.

PGRP-L is the only PGRP that has the full complement of conserved amino acids necessary for enzyme activity; PGRP-L has N-acetylmuramoyl-L-alanine amidase activity (46, 209). The minimum peptidoglycan structure cleaved by PGRP-L is N-acetylmuramic acid tripeptide (209). PGRP-L resembles the serum amidase in its molecular mass and specificity of the substrate. Although PGRP-L is predicted to be a transmembrane protein, it has been found in the serum (104, 218). The serum amidase is present in the extracellular compartment but is also tissue bound. This suggests that PGRP-L is likely to be the serum/tissue amidase (34, 209).

Predigestion with lysozyme is required for mouse PGRP-L to effectively hydrolyze staphylococcal peptidoglycan (46). Amidases inactivate the proinflammatory activities of peptidoglycan by degrading its structure (68, 116). Thus, the combined action of lysozyme and PGRP-L might inactivate staphylococcal peptidoglycan and reduce peptidoglycan-induced inflammation. However, a recent study shows that no differences in mortality are observed between wild-type and PGRP-L-deficient mice challenged with S. aureus. Furthermore, S. aureus stimulation induces similar IL-6 and